NVS · SUB · EC · ISSFA

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «NOVARTIS ECUADOR S.A.» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 3 non-competitive contracts at the buyer «ISSFA», 227,435 USD (≈ $227,435); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-093-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS; OCID ocds-5wno2w-RE-ISSFA-2021-012-2803, ocds-5wno2w-RE-ISSFA-2021-022-2803, ocds-5wno2w-CE-20240002570115-2803; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

NVS · SUB · EC · ISSFA

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

227,435

Records behind the indicator

3

Found

4 October 2026

Code

W-01621

Reference

SICM-093-2022

Reference

ocds-5wno2w-RE-ISSFA-2021-012-2803

Reference

ocds-5wno2w-RE-ISSFA-2021-022-2803

Reference

ocds-5wno2w-CE-20240002570115-2803

Reference

2020-06-25

Reference

2016-03-23